Industry News
-
uniQure Advances AAV Gene Therapy AMT-130 for Huntington’s Disease
Jul 29 2025 -
Adaptimmune Sells Cell Therapy Assets to US WorldMeds
Jul 28 2025 -
Genethon Receives Regulatory Approvals for Pivotal Phase 3 AAV Gene Therapy Trial for DMD in Europe
Jul 28 2025 -
FDA Allows Sarepta to Resume Its AAV Gene Therapy Shipments for Ambulatory Duchenne Patients
Jul 28 2025 -
EMA Rejects Marketing Authorization for Sarepta’s DMD AAV Gene Therapy
Jul 25 2025 -
Lyell Immunopharma Secures Up To $100 Million in Private Placement
Jul 25 2025 -
Genflow Biosciences Advances Key AAV Longevity Programs GF-1002 and GF-1004
Jul 24 2025 -
Pierre Fabre Pharmaceuticals and Atara Biotherapeutics Advance Cell Therapy with FDA Priority Review
Jul 24 2025 -
Solid Biosciences’ AAV Gene Therapy SGT-501 Granted FDA Fast Track for CPVT
Jul 23 2025